The discharge summary for Ms. ___ provides a comprehensive overview of her hospitalization, including diagnoses, treatments, and transitional plans. Here is a concise and organized presentation of the key points:

---

**Patient:** Ms. ___
**Discharge Date:** [Date]

### **Primary Diagnoses:**
1. Hypotension
2. Hyperkalemia
3. Acute Kidney Injury

### **Secondary Diagnoses:**
1. HIV
2. Cirrhosis (HCV Genotype 3a, decompensated)
3. COPD (on 3L oxygen therapy)

---

### **Treatment and Outcomes:**
- **Mental Status:** Improved with lactulose.
- **Blood Pressure:** Improved with fluid administration.
- **Hyperkalemia:** Resolved with treatment.
- **Acute Kidney Injury:** Improved with fluids.

### **Medications:**
**On Admission:**
1. Lactulose 15 mL PO TID
2. Tiotropium Bromide 1 CAP IH DAILY
3. Raltegravir 400 mg PO BID
4. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY
5. Furosemide 40 mg PO DAILY
6. TraMADOL (Ultram) 50 mg PO Q8H:PRN Pain
7. Fluticasone Propionate 110mcg 1 PUFF IH BID
8. Calcium Carbonate 500 mg PO BID
9. Rifaximin 550 mg PO BID
10. Albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing
11. Sulfameth/Trimethoprim DS 1 TAB PO DAILY

**Discharge Medications:**
1. Calcium Carbonate 500 mg PO BID
2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY
3. Fluticasone Propionate 110mcg 1 PUFF IH BID
4. Lactulose 30 mL PO TID
5. Raltegravir 400 mg PO BID
6. Rifaximin 550 mg PO BID
7. TraMADOL (Ultram) [ dosage unspecified ] PO Q6H:PRN pain
8. Albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN Wheezing
9. Tiotropium Bromide 1 CAP IH DAILY

---

### **Transitional Issues and Follow-Up:**
- **Palliative Care:** Follow-up as an outpatient.
- **Bactrim Prophylaxis:** Held during hospitalization; consider restarting as an outpatient.
- **Furosemide:** Held due to hyperkalemia; consider restarting as an outpatient.
- **Hepatology Follow-Up:** Required.
- **Therapeutic Paracenteses:** Continue biweekly.

### **Code Status:**
- DNR/DNI

---

### **Discharge Instructions:**
Ms. ___ was discharged home in stable condition with clear mental status, alertness, and ambulatory independence. She is instructed to follow up with palliative care and continue her current medications as outlined.

**Dear Ms. ___,**

Your confusion improved with lactulose, blood pressure stabilized with fluids, and hyperkalemia resolved. Your kidney function also improved. You discussed changing your goals of care to focus on symptom management. Follow-up with palliative care is crucial for your ongoing care.

---

This summary ensures all necessary information is clear and actionable for the patient's continued treatment and follow-up.